Deciphex launches diagnostics as a service (DxaaS) in the United States

September 13, 2022 – Deciphex, a Dublin, Ireland-based provider of digital pathology software and services, has announced the launch of its Diagnexia service in the United States. The announcement was made at the annual meeting of the American Society for Clinical Pathology (ASCP), held in Chicago September 7-9, 2022, on the occasion of the Society’s 100th anniversary.

The Diagnexia Virtual Pathology Service provides on-demand access to remote subspecialty experts for pathology consultation services on an advanced collaborative platform. This provides important support to overburdened and understaffed pathology departments without available experts in every subspecialty, the statement noted. Diagnexia is the first all-digital, subspecialty-led remote diagnostic and consultation service, offering a global network of subspecialty pathology experts to reduce pathology bottlenecks, speed diagnoses and improve patient outcomes.

The platform connects laboratories to an international network of subspecialty pathologists, who can provide expertise on clinical cases, while dramatically reducing turnaround times and ensuring the highest quality care is delivered to patients. Busy academic teams within hospital networks will also benefit from the availability of additional experts on request to help balance workloads. Eligible retired pathologists can join the Diagnexia network and work remotely on a part-time basis.

The company’s statement noted that pathology is heading towards a tipping point due to increasing volumes, growing complexity and stable or declining numbers of pathologists. Pathologists are in high demand around the world and their numbers are expected to decline significantly over the next ten years. The Deciphex platform will enable leading cancer centers in the United States to use digital pathology to:

– Improve patient care with the right pathologist viewing the right slide at the earliest possible time.

– Reduce costs by moving to a digital workflow, the sending and receiving institution saves on packaging, shipping costs and employee time.

– Eliminate data entry (and potential errors) during the intake and opt-in stage with LIS integration

Donald O’Shea, Deciphers Chief Executive Officer, offered this in the announcement:

“The launch of Diagnexia in the United States is an important step for the company in its ambition to use digital pathology and AI to provide easy access to the world’s best pathologists. Chronic problems in pathology, such as increasing patient wait times, recruitment, demand for expertise, and diagnostic complexity, have required a new approach to improving patient care. Even well-resourced health systems with a “relatively high density of pathologists” have a chronic lack of capacity, leading to backlogs, delays in diagnosis, care and patient outcomes. The ability to mitigate these challenges with transparent cutting-edge technology is a game-changer and ultimately has enormous benefits for patients, healthcare services and pathology labs.

Deciphex is a key member of BigPicture (bigpicture.eu), a major EU-funded initiative to build the world’s largest central repository of digital pathology slides to drive the development of AI.

For more information: https://www.deciphex.com/

Comments are closed.